<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03096236</url>
  </required_header>
  <id_info>
    <org_study_id>RESET</org_study_id>
    <nct_id>NCT03096236</nct_id>
  </id_info>
  <brief_title>Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD</brief_title>
  <acronym>RESET</acronym>
  <official_title>Endoscopic Full-thickness Resection of Gastric Subepithelial Tumors With the gFTRD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kliniken Ludwigsburg-Bietigheim gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kliniken Ludwigsburg-Bietigheim gGmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subepithelial gastric tumors are rare and usually detected incidentally. Most subepithelial
      tumors (SET) are benign but up to 13% of all lesions can be malignant. Histology after needle
      biopsy often brings no clear diagnosis in SET, so further strategy often remains unclear.
      Surveillance endoscopy can be associated with the risk of progression. Endoscopic resection
      usually is difficult, associated with high risk of complications and sometimes is not
      feasible. Surgical resection is also associated with a risk of complications and often
      refused by the patients. With the developement of the gFTRD-System gastric SET can now be
      resected endoscopically. The advantage of this technique is the complete resection and a
      full-thickness resections specimen for are definite histology.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">September 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Technical success</measure>
    <time_frame>1 minute (immediate)</time_frame>
    <description>Successful enbloc- and macroscopically complete resection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>R0-Resection</measure>
    <time_frame>three days</time_frame>
    <description>Histologically confirmed complete resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histologically confirmed full thickness resection</measure>
    <time_frame>three days</time_frame>
    <description>Histologically confirmed full thickness resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedure-associated complications</measure>
    <time_frame>three months</time_frame>
    <description>Procedure-associated complications such as bleeding or perforation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessity of surgical treatment</measure>
    <time_frame>three months</time_frame>
    <description>Necessity of surgical treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Residual or recurrent adenoma/carcinoma at endoscopic follow up</measure>
    <time_frame>three months</time_frame>
    <description>Residual or recurrent adenoma/carcinoma at endoscopic follow up</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Feasibility, Complications</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EFTR</intervention_name>
    <description>EFTR with the FTRD developed for gastric resection (gFTRD).</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with gastric SET
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Gastric SET up to 15 mm (measurement: endoscopic ultrasound)

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Gastric SET &gt; 15 mm and/or large extramural part

          -  Criteria of Lipoma (endoscopic ultrasound)

          -  Positive lymph nodes (endoscopic ultrasound)

          -  Stenosis (Esophagus)

          -  Diverticulum (Esophagus)

          -  Pregnancy or Nursing period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Meier</last_name>
      <email>benjamin.meier@kliniken-lb.de</email>
    </contact>
    <contact_backup>
      <last_name>Karel Caca</last_name>
      <phone>004971419967201</phone>
      <email>karel.caca@kliniken-lb.de</email>
    </contact_backup>
    <investigator>
      <last_name>Karel Caca, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2017</study_first_submitted>
  <study_first_submitted_qc>March 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2017</study_first_posted>
  <last_update_submitted>September 15, 2017</last_update_submitted>
  <last_update_submitted_qc>September 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

